Actively Recruiting
Nephroprotective Measures in Critically Ill Patients With Moderate/Severe Acute Kidney Injury
Led by Universität Münster · Updated on 2024-12-12
257
Participants Needed
3
Research Sites
57 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study investigates to which extent recommended nephroprotective measures are implemented in critically ill patients with moderate or severe acute kidney injury.
CONDITIONS
Official Title
Nephroprotective Measures in Critically Ill Patients With Moderate/Severe Acute Kidney Injury
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Critically ill patients with moderate or severe AKI (KDIGO stage 2 / 3)
- Requirement of vasopressors or mechanical ventilation
- Age 65 18 years
- Informed consent
You will not qualify if you...
- Chronic kidney disease (CKD) with a glomerular filtration rate < 20ml/min
- Chronic dialysis dependency
- History of renal transplantation
- Permanent ligation of the renal arteries
- AKI immediately following nephrectomy
- Patients requiring permanent administration of nephrotoxic drugs (e.g. immunosuppressive therapy after liver transplantation)
- Persons with any kind of dependency on the investigator or employed by the sponsor or investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Universitätsklinik Innsbruck
Innsbruck, Austria, 6020
Actively Recruiting
2
University Hospital Münster; Department of Anesthesiology, Intensive Care Medicine and Pain Medicine
Münster, Germany, 48149
Actively Recruiting
3
Radboud University medical cener
Nijmegen, Netherlands, 6500
Actively Recruiting
Research Team
M
Melanie Meersch-Dini, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here